The most common AEs included hot flush, injection site burning, fatigue, testicular atrophy, and gynecomastia.
In all of these studies, the most common AEs were hot flush, injection site reactions, and fatigue.
During in vivo porcine experiments when investigating the threshold condition of appropriate flush injection rate, EV-OCT signal intensity varied significantly depending on completeness of blood displacement by flushing fluid pump injections (contrast/saline mixture).
The volumetric flow rate applied at the inlet was 5 ml/s, similar to typical saline flush injection rate used for the porcine experiments.
From a clinical perspective, this is the threshold condition for determining the minimal contrast/saline flush injection rate for a particular blood vessel and its associated flow rate, to achieve optical clearing condition for imaging while maintaining flow.
These reports led to a major recall, first in the USA and then Europe, of heparin batches, heparin coated medical devices, and lock flush-injections that used heparin as the active pharmaceutical ingredient.
Three days after hospital admission, the patient exhibited facial flushing, conjunctival injection, and polyuria.
Flushing and injection site reactions were the most commonly reported AEs.
It was not until the patient developed facial flushing, conjunctival injection and polyuria that the conditions of high fever, thrombocytopenia and acute renal insufficiency were considered with more emphasis and the patient was properly diagnosed with HFRS complicated with AP.
Either a miRNA-specific or a non-targeting mimic was applied starting the Day 0 of tumour induction intrathecally until PID-8 at 2 nmol/injection in 5 µl PBS followed by 5 µl saline flush (see injection scheme in Fig 2, panel A).
